Pandemic influenza due to pH1N1/2009 virus: Estimation of infection burden in Reunion Island through a prospective serosurvey, Austral Winter 2009

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Dellagi, Koussay ^a,b   Rollot, Olivier ^c   Temmam, Sarah ^a,d   Salez, Nicolas ^e   Guernier, Vanina ^a,b   Pascalis, Hervé ^a,b   Gérardin, Patrick ^c   Fianu, Adrian ^c   Lapidus, Nathanael ^f   Naty, Nadège ^c   Tortosa, Pablo ^a,g   Boussaïd, Karim ^c   Jaffar Banjee, Marie Christine ^h   Filleul, Laurent ⁱ   Flahault, Antoine ^j   Carrat, Fabrice ^f   Favier, Francois ^c   de Lamballerie, Xavier ^e  

^a GIS CRVOI Centre de Recherche et de Veille sur les Maladies Emergentes dans l'Océan Indien   (Reunion)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c Centre Hospitalier Régional   (Reunion)

^d UNIVERSITÉ DE LYON   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g Chaire mixte CNRS INEE Université de La Réunion   (Reunion)

^h Centre Hospitalier Regional   (Reunion)

ⁱ EHESP Rennes Sorbonne Paris Cité ^*  (Reunion)

^j EHESP SCHOOL OF PUBLIC HEALTH   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CHILD; EPIDEMIC; FEMALE; FRANCE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INCIDENCE; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; VIRUS DETECTION; WINTER; BLOOD; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; PANDEMIC; PATHOGENICITY; POLYMERASE CHAIN REACTION; SEASON; VIROLOGY;

ADULT; COHORT STUDIES; FEMALE; FRANCE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMICS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SEASONS; SEROLOGIC TESTS; YOUNG ADULT;

EID: 80053332921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025738     Document Type: Article

References (46)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
2. Cowling BJ, Chan KH, Fang VJ, Lau LLH, So HC, et al. (2010) Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 362: 2175-2184.
3. Lipsicht M, Hayden FG, Cowling BJ, Leung GM, (2009) How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet 374: 1209-1211.
4. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
5. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
6. Chen MIC, Lee VJM, Wei-Yein L, Barr IG, Lin RTP, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among district adult cohorts in Singapore. JAMA 303: 1383-1391.
7. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA. PLoS One 5: e11601.
8. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 5: e13211.
9. Lim WY, Chen CH, Ma Y, Chen MI, Lee VJ, et al. (2011) Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009. Emerg Infect Dis 17 (8): 1455-1462.
10. Huo X, Qi X, Tang F, Zu R, Li L, et al. (2011) Seroprevalence of pandemic (H1N1) 2009 in pregnant women in China: an observational study. PLoS One 6 (3): e17995.
11. Chao DY, Cheng KF, Li TC, Wu TN, Chen CY, et al. (2011) Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico. PLoS One 6 (1): e14555.
12. D'Ortenzio E, Renault P, Jaffar-Bandjee MC, Gaüzère BA, Lagrange-Xélot M, et al. (2010) A review of the dynamics and severity of the pandemic A(H1N1) influenza virus on Réunion island, 2009. Clin Microbiol Infect16: 309-316.
13. Renault P, D'Ortenzio E, Kermarec F, Filleul L, (2010) Pandemic influenza 2009 on Réunion Island: A mild wave linked to a low reproduction number. PLoS Curr 2: RRN1145.
14. Gérardin P, El Amrani R, Cyrille B, Gabrièle M, Guillermin P, et al. (2010) Low clinical virulence of 2009 pandemic influenza A (H1N1) infection during pregnancy on the island of La Réunion. PLoS One 5: e10896.
15. Gérardin P, Guernier V, Perrau J, Fianu A, Le Roux K, et al. (2008) Estimating Chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 8: 99.
16. Gérardin P, Fianu A, Malvy D, Mussard C, Boussaïd K, et al. (2011) Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med.In press.
17. Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, et al. (2011) Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clin Microbiol Infectdoi:10.1111/j.1469-0691.2011.03545.x.
18. Nougairède A, Ninove L, Zandotti C, Salez N, Mantey K, et al. (2010) Novel virus influenza A (H1N1sw) in South-Eastern France, April-August 2009. PLoS One 5: e9214.
19. Henderson AR, (2005) The bootstrap: a technique for data-driven statistics. Using comuter-intensivz analysis to explore experimental data. Clin Chim Acta 359: 1-26.
20. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
21. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, et al. (2011) Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations. J Clin Microbiol 49 (6): 2210-2215.
22. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15: 19478.
23. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-3562.
24. Chi C, Liu C, Lin C, Wang H, Cheng Y, et al. (2010) Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population. Clin Vaccine Immunol 17: 1958-1962.
25. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.
26. Booy R, Khandaker G, Heron LG, Yin J, Doyle B, et al. (2011) Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust 194 (1): 19-23.
27. Waalen K, Kilander A, Dudman S, Krogh G, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15: 19633.
28. Xu C, Bai T, Iuliano AD, Wang M, Yang L, et al. (2011) The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One 6 (4): e17919.
29. Glezen WP, (1996) Emerging infections: pandemic influenza. Epidemiol Rev 18: 64-76.
30. Zimmer SM, Burke DS, (2009) Historical perspective-Emergence of influenza A (H1N1) viruses. N Engl J Med 361: 279-285.
31. Centers for Disease Control and Prevention (CDC) (2009) Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine. MMWR Morb Mortal Wkly Rep 58: 521-524.
32. Dudareva S, Schweiger B, Thamm M, Höhle M, Stark K, et al. (2011) Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One 6 (6): e21340.
33. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, et al. (2011) Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 203 (2): 158-167.
34. Kelly HA, Mercer GN, Fielding JE, Dowse GK, Glass K, et al. (2010) Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America. PLoS One 5 (6): e11341.
35. Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, et al. (2010) Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infectdoi:10.1111/j.1469-0691.2010.03352.x.
36. Johns MC, Eick AA, Blazes DL, Lee S, Perdue CL, et al. (2010) Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel. PLoS One 5: e10722.
37. Lee VJ, Tay JK, Chen MIC, Phoon MC, Xie ML, et al. (2010) Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 28: 6852-6857.
38. Soonawala D, Rimmelzwaan GF, Gelinck LB, Visser LG, Kroon FP, (2011) Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination. PLoS One 6 (1): e16496.
39. Xie H, Jing X, Li X, Lin Z, Plant E, et al. (2011) Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS One 6 (1): e16650.
40. Labrosse B, Tourdjman M, Porcher R, LeGoff J, de Lamballerie X, et al. (2010) Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay. PLoS One 5: e11036.
41. Ghani AC, Baguelin M, Griffin J, Flasche S, Pebody R, et al. (2009) The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr 1: RRN1130.
42. Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, et al. (2010) Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses 2: 782-795.
43. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, et al. (2011) Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS One 6 (2): e17074.
44. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
45. Wang M, Yuan J, Li T, Liu Y, Wu J, et al. (2011) Antibody dynamics of 2009 influenza A (H1N1) virus in infected patients and vaccinated people in China. PLoS One 6 (2): e16809.
46. Cire Océan Indien (2010) Surveillance de la grippe à la Réunion. Point épidémiologique n°80 (26/11/2010). Available:http://www.invs.sante.fr/regions/reunion_mayotte/pe_rm_grippe_80_261110.pdf.